For example, it was recently demonstrated that antibody targeting of MARCO-expressing TAMs blocked tumor growth and metastasis, and also enhanced the effects of immune checkpoint therapy in melanoma and colon carcinoma models [44]. Here, MARCO is linked to colon carcinoma.